نتائج البحث 391-400 من 1301 لعملية البحث عن total t4
The primary objective of the study is to evaluate the Overall Survival (OS). التصفّح دراسات سريرية. السابقالصفحة السابقة · توجّه للصفحة 22 · توجّه للصفحة 33 ...
Complete response is at 3 or 6 months defined as absence of any UTUC in the renal pelvis. IMC-F106C Regimen Versus Nivolumab Regimens in Previously ...
... complete remission (no evidence of disease). This is an investigational study. Radiation therapy is delivered using FDA-approved and commercially available ...
Subjects in the Biobank will provide samples of excess breast tissue, complete a health questionnaire, and allow access to medical records now and in the future ...
Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...
Increasing CLL patients overall physical fitness levels, through exercise during the observation stage, may provide a realistic approach means to increase ...
The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple system atrophy and Parkinson's disease at early clinical ...
Complete response is at 3 or 6 months defined as absence of any UTUC in the renal pelvis. Undiagnosed Tumor/Undifferentiated Mass Registry. Rochester, Minn ...
... total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in ...
A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.